Kenvue Inc. (KVUE): A Bull Case Theory [Yahoo! Finance]
Kenvue Inc. (KVUE)
Company Research
Source: Yahoo! Finance
Kenvue Inc.'s share was trading at $18.66 as of February 19th. KVUE's trailing and forward P/E were 24.93 and 17.01, respectively according to Yahoo Finance. Johnson & Johnson JNJ headache tylenol pain acetaminophen pill relief display health Niloo / Shutterstock.com Kenvue, the newly independent consumer health company spun out from Johnson & Johnson, operates a portfolio of category-leading brands such as Tylenol, Neutrogena, and Listerine, giving it moderate but meaningful competitive advantages. These brands command pricing power and retailer shelf-space, supported by global scale and distribution that reduce vulnerability versus regional players. While brand equity underpins a moat, the consumer health space is not structurally high-moat—competition from generics, private labels, and shifting consumer trends, along with pressure from e-commerce and brick-and-mortar retail, can erode advantages over time. The business is straightforward, offering well-understood products a
Show less
Read more
Impact Snapshot
Event Time:
KVUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KVUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KVUE alerts
High impacting Kenvue Inc. news events
Weekly update
A roundup of the hottest topics
KVUE
News
- Here's Why SCCM Enhanced Equity Portfolio Exited Its Position in Kenvue (KVUE) [Yahoo! Finance]Yahoo! Finance
- Kenvue (NYSE:KVUE) was given a new $18.00 price target on by analysts at Canaccord Genuity Group Inc..MarketBeat
- Kenvue (NYSE:KVUE) had its "neutral" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Kenvue (NYSE:KVUE) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Kenvue Reports Fourth Quarter and Full Year 2025 ResultsBusiness Wire
KVUE
Earnings
- 2/17/26 - Beat
KVUE
Sec Filings
- 2/20/26 - Form 10-K
- 2/18/26 - Form 4
- 2/18/26 - Form 4
- KVUE's page on the SEC website